Table 3 AEs during NTB treatment
Adverse events (AEs) | Total (n = 26) | NTB group (n = 15) | NTB + IS group (n = 11) | P |
|---|---|---|---|---|
Diarrhea | 14 (53.9) | 9 (60.0) | 5 (45.5) | 0.692 |
Elevated liver enzymes | 2 (7.7) | 2 (13.3) | 0 (0) | 0.492 |
Nausea | 1 (3.9) | 0 (0) | 1 (9.1) | 0.423 |
Headache | 1 (3.9) | 0 (0) | 1 (9.1) | 0.423 |
Gastrointestinal perforation | 1 (3.9) | 0 | 1 (9.1) | 0.423 |
Dose reduction | 11 (42.3) | 6 (40.0) | 5 (45.5) | 1.000 |
Reasons for dose reduction | Â | Â | Â | Â |
Diarrhea | 8 (30.8) | 4 (26.7) | 4 (36.4) | 0.683 |
Elevated liver enzymes | 2 (7.7) | 2 (13.3) | 0 (0) | 0.492 |
Nausea | 1 (3.9) | 0 | 1 (9.1) | 0.423 |
Discontinuation | 0 (0) | 0 (0) | 0 (0) | ― |